NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

EW

Edwards Lifesciences Corp

Jul 09 • 04:00PM ET

77.19

Dollar change +0.80
Percentage change 1.05	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO VO SPY IVV VTV VOT XLV IHI RSP

Scroll to Statements

Index	S&P 500	P/E	51.57	EPS (ttm)	1.50	Insider Own	2.03%	Shs Outstand	586.20M	Perf Week	0.01%
Market Cap	45.28B	Forward P/E	28.00	EPS next Y	2.76	Insider Trans	-1.09%	Shs Float	574.69M	Perf Month	-0.43%
Enterprise Value	42.14B	PEG	6.02	EPS next Q	0.62	Inst Own	87.64%	Short Float	1.06%	Perf Quarter	11.87%
Income	887.90M	P/S	8.17	EPS this Y	1.72%	Inst Trans	0.80%	Short Ratio	1.44	Perf Half Y	4.44%
Sales	5.54B	P/B	4.47	EPS next Y	11.54%	ROA	12.68%	Short Interest	6.07M	Perf YTD	4.27%
Book/sh	17.28	P/C	11.61	EPS next 5Y	8.56%	ROE	16.73%	52W High	95.25 -18.96%	Perf Year	-16.39%
Cash/sh	6.65	P/FCF	71.52	EPS past 3/5Y	-15.06% -2.36%	ROIC	8.22%	52W Low	58.93 30.99%	Perf 3Y	-20.74%
Dividend Est.	-	EV/EBITDA	25.63	Sales past 3/5Y	1.30% 4.58%	Gross Margin	78.59%	Volatility	1.77% 1.92%	Perf 5Y	11.87%
Dividend TTM	-	EV/Sales	7.61	EPS Y/Y TTM	-35.77%	Oper. Margin	26.92%	ATR (14)	1.47	Perf 10Y	225.17%
Dividend Ex-Date	-	Quick Ratio	3.66	Sales Y/Y TTM	-9.84%	Profit Margin	16.03%	RSI (14)	55.60	Recom	2.19
Dividend Gr. 3/5Y	- -	Current Ratio	4.45	EPS Q/Q	6.66%	SMA20	1.49%	Beta	1.08	Target Price	81.46
Payout	0.00%	Debt/Eq	0.07	Sales Q/Q	-11.61%	SMA50	1.29%	Rel Volume	0.61	Prev Close	76.39
Employees	15800	LT Debt/Eq	0.07	Earnings	Jul 24 AMC	SMA200	7.28%	Avg Volume	4.23M	Price	77.19
IPO	Mar 27, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.29% 0.87%	Trades		Volume	2,635,591	Change	1.05%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-24-25	Upgrade	Piper Sandler	Neutral → Overweight	$80
Jan-30-25	Upgrade	Stifel	Hold → Buy	$75 → $90
Jan-16-25	Downgrade	Wolfe Research	Peer Perform → Underperform	$60
Dec-16-24	Upgrade	BofA Securities	Neutral → Buy
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70
Jul-25-24	Downgrade	JP Morgan	Overweight → Neutral	$105 → $72
Jul-25-24	Downgrade	BofA Securities	Buy → Neutral	$105 → $75
May-30-24	Initiated	Goldman	Buy	$107
May-22-24	Upgrade	Citigroup	Neutral → Buy	$98 → $105
May-14-24	Upgrade	Deutsche Bank	Hold → Buy
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral

Show Previous Ratings

Jul-03-25 06:12AM	Earnings Preview: What To Expect From Edwards Lifesciences' Report (Barchart)
Jun-24-25 09:07AM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
08:55AM	NYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East (PR Newswire)
08:27AM	BSX Raises 2025 Financial Outlook: What's Backing It? (Zacks)
Jun-17-25 09:37AM	ISRG's Minimally Invasive Ecosystem Powers Surgical Precision (Zacks)
04:08PM	Loading…
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
May-30-25 11:31AM	Why Is Accuray (ARAY) Up 17% Since Last Earnings Report? (Zacks)
May-28-25 10:17AM	How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott (Investor's Business Daily)
10:14AM	How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals (Investor's Business Daily)
May-23-25 11:39AM	Edwards study demonstrates value in early aortic stenosis intervention (Medical Device Network)
08:53AM	Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock (Zacks)
May-22-25 09:18AM	Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick (Investing.com)
02:30AM	Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes (Business Wire)
May-20-25 08:58PM	Jim Cramer Notes Edwards Lifesciences (EW) is in a "Good Zone" (Insider Monkey)
May-19-25 08:30PM	Lightning Round: Zoom is doing a lot right, but it's taking them a really long time, says Jim Cramer (CNBC TV)
02:30PM	Loading…
02:30PM	Trade Tracker: Bill Baruch buys Edwards Lifesciences (CNBC TV)
May-16-25 06:34AM	Should Edwards Lifesciences Stock Remain in Your Portfolio Now? (Zacks)
May-09-25 07:46AM	Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now (Insider Monkey)
May-07-25 05:24PM	Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific (Zacks)
May-06-25 07:05AM	Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
May-01-25 12:16PM	FDA approves Edwards TAVR system for asymptomatic aortic stenosis patients (Medical Device Network)
08:00AM	Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis (Business Wire)
Apr-30-25 08:03PM	Edwards Lifesciences Corporation (EW): Jim Cramer Says It's a Hold - But Is Boston Scientific Now His Favorite? (Insider Monkey)
Apr-24-25 08:01PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research) +6.63%
04:12PM	Edwards Shoots Higher As It Shrugs Off Tariffs Worries Until 2026 (Investor's Business Daily)
09:34AM	Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls (The Fly)
08:50AM	Q1 2025 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
07:04AM	Edwards shrugs off tariffs, backs 2025 profit forecast (MedTech Dive)
06:43AM	EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised (Zacks)
03:08AM	Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
09:52PM	Loading…
Apr-23-25 09:52PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
09:35PM	Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:00PM	Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:41PM	Why Heart-Focused Edwards Lifesciences Isn't Worried About Tariffs (Investor's Business Daily)
04:41PM	Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat (Investor's Business Daily)
04:15PM	Edwards Lifesciences Reports First Quarter Results (Business Wire)
Apr-21-25 06:00AM	Intuitive, Boston Scientific and Edwards next up in medtech earnings (MedTech Dive)
Apr-19-25 08:25AM	Edwards says eight-year data confirm long-term durability of Resilia tissue (TipRanks)
Apr-18-25 09:15AM	Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics (Zacks)
08:00AM	Eight-Year Data Confirm Long-Term Durability of Edwards RESILIA Tissue (Business Wire)
Apr-17-25 08:31AM	Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings (Zacks)
Apr-16-25 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025 (Business Wire)
Apr-14-25 11:33PM	Edwards receives CE mark for Sapien M3 mitral valve replacement device (MedTech Dive)
12:07PM	Edwards secures CE mark for transfemoral mitral valve implant (Medical Device Network)
08:00AM	Edwards SAPIEN M3 Receives CE Mark, Becoming Worlds First Transfemoral Transcatheter Mitral Valve Replacement System (Business Wire)
Apr-10-25 08:10AM	Harbor Long-Term Growers ETF Q4 2024 Commentary (Seeking Alpha)
Apr-03-25 02:23PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
Apr-01-25 09:18AM	Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities (Insider Monkey)
Mar-31-25 02:00PM	New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients (Business Wire)
09:43AM	Jim Cramer Calls Edwards Lifesciences (EW) a Hold - Prefers Boston Scientific Right Now! (Insider Monkey)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
02:50AM	abrdn Healthcare Investors Q4 2024 Commentary (Seeking Alpha)
Mar-22-25 11:51PM	Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead (SeekingAlpha)
Mar-20-25 02:04PM	Medtronics Evolut trial outcome could shift US TAVR market (Medical Device Network)
Mar-10-25 08:19PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
03:17PM	Edwards Lifesciences Corporation (EW): Among the Top Stocks to Buy According to Citadel Investment Group (Insider Monkey)
Feb-25-25 07:05AM	Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference (Business Wire)
Feb-12-25 05:12PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research) +6.92%
04:15PM	Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion (Investor's Business Daily)
02:51PM	Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength (Benzinga)
09:55AM	Q4 2024 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
09:16AM	Is Edwards Lifesciences Corporation (EW) the Best Medical Device Stock to Buy? (Insider Monkey)
02:13AM	Edwards Lifesciences Corp (EW) Q4 2024 Earnings Call Highlights: Strong Full-Year Growth and ... (GuruFocus.com)
Feb-11-25 09:54PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
04:29PM	Edwards Pops On Fourth-Quarter Beat As Heart-Valve Replacements Top $1 Billion (Investor's Business Daily)
04:29PM	Edwards Beats Fourth-Quarter Forecasts, But Shares Slip (Investor's Business Daily)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
Feb-10-25 08:01AM	Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-06-25 09:15AM	Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics (Zacks)
Feb-04-25 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025 (Business Wire)
Jan-31-25 03:14PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
Jan-30-25 02:21PM	Edwards Lifesciences Is Poised For Solid Growth In 2025Analyst Highlights TAVR Growth, Margin Expansion (Benzinga)
Jan-28-25 10:00AM	Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-21-25 05:22PM	Masimo Taps Katie Szyman as Permanent CEO (The Wall Street Journal)
Jan-16-25 08:17AM	Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)? (Insider Monkey)
Jan-07-25 07:05AM	Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-03-25 06:46AM	Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI (TipRanks)
Jan-02-25 05:42AM	Top 10 medtech deals of 2024 (MedTech Dive)
Dec-28-24 05:01PM	Edwards Lifesciences Corporation (EW): Among the Cheap Healthcare Stocks to Buy Heading Into 2025 (Insider Monkey)
Dec-20-24 04:04PM	Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback? (Insider Monkey)
08:53AM	Is the Options Market Predicting a Spike in Edwards (EW) Stock? (Zacks)
06:48AM	CMS proposes Medicare coverage for transcatheter tricuspid replacement (MedTech Dive)
Dec-12-24 06:50AM	Capstan Medical raises $110M for heart valve with robotic system (MedTech Dive)
Dec-05-24 07:17AM	Edwards expects new TAVR approval in mid-2025 to boost sales (MedTech Dive)
Dec-04-24 07:41PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research) +5.70%
04:41PM	S&P 500 Gains and Losses Today: Salesforce Stock Pops as AI Offering Impresses (Investopedia)
11:40AM	Edwards Lifesciences Outlines Vision For Growth At Investor Conference (Benzinga)
06:17AM	Edwards Lifesciences Projects 2025 Constant Currency Sales Growth Of 8% - 10% (RTT News)
06:00AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Dec-02-24 05:45AM	Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi and Korsinsky for More Information - EW (PR Newswire)
Nov-25-24 07:49AM	Edwards Lifesciences announces positive results in one year TAVI trial (Clinical Trials Arena)
03:30AM	Edwards' SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data (Business Wire)
Nov-15-24 05:45AM	Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW (PR Newswire)
Nov-13-24 12:49PM	Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights EW (GlobeNewswire)
10:28AM	US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024 (Medical Device Network)
Nov-12-24 05:45AM	Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW (PR Newswire)
Nov-09-24 12:19AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Nov-02-24 11:13AM	Kessler Topaz Meltzer & Check, LLP Encourages Edwards Lifesciences Corporation Investors with Losses to Contact the Firm (Newsfile)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Option Exercise	59.26	8,950	530,347	215,850	Jun 16 05:09 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Sale	75.23	8,950	673,268	206,900	Jun 16 05:09 PM
Wood Larry L	Officer	Jun 16 '25	Proposed Sale	75.23	8,950	673,268		Jun 16 04:20 PM
Zovighian Bernard J	CEO	May 30 '25	Sale	77.21	16,099	1,243,065	9,564	Jun 03 05:15 PM
Zovighian Bernard J	CEO	Jun 03 '25	Sale	77.32	967	74,772	8,597	Jun 03 05:15 PM
Zovighian Bernard J	Officer	Jun 03 '25	Proposed Sale	77.32	967	74,772		Jun 03 04:29 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 02 '25	Sale	77.40	2,570	198,911	50,356	Jun 02 05:01 PM
BOBO DONALD E JR	Officer	Jun 02 '25	Proposed Sale	77.40	2,570	198,911		Jun 02 04:03 PM
Zovighian Bernard J	Officer	May 30 '25	Proposed Sale	77.21	16,099	1,243,064		May 30 04:31 PM
Chopra Daveen	CVP, TMTT	May 22 '25	Sale	75.08	1,500	112,612	33,496	May 22 05:08 PM
Chopra Daveen	Officer	May 22 '25	Proposed Sale	75.07	1,500	112,612		May 22 04:01 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Option Exercise	45.28	330	14,941	26,946	May 09 07:35 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Sale	74.42	330	24,560	26,616	May 09 07:35 PM
Markowitz Wayne	GM & SVP, Surgical	May 07 '25	Sale	75.08	268	20,121	9,299	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Option Exercise	45.28	11,250	509,363	52,348	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Sale	74.40	11,250	837,035	41,098	May 09 07:34 PM
Lippis Daniel J.	Officer	May 09 '25	Proposed Sale	74.42	330	24,560		May 09 04:00 PM
Markowitz Wayne	Officer	May 07 '25	Proposed Sale	75.08	268	20,121		May 07 04:48 PM
Zovighian Bernard J	CEO	May 05 '25	Option Exercise	45.28	7,462	337,855	65,746	May 06 05:13 PM
Zovighian Bernard J	CEO	May 05 '25	Sale	74.91	5,980	447,977	58,284	May 06 05:13 PM
Zovighian Bernard J	Officer	May 05 '25	Proposed Sale	74.91	5,980	447,977		May 05 04:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Option Exercise	45.28	9,500	430,129	56,706	Apr 14 06:18 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Sale	69.81	9,500	663,196	47,206	Apr 14 06:18 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Option Exercise	45.28	300	13,583	23,163	Apr 08 05:12 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Sale	70.61	300	21,183	22,863	Apr 08 05:12 PM
Lippis Daniel J.	Officer	Apr 08 '25	Proposed Sale	70.61	300	21,183		Apr 08 04:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Option Exercise	45.28	11,250	509,363	41,637	Mar 26 04:45 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Sale	70.87	11,250	797,267	30,387	Mar 26 04:45 PM
Ullem Scott B.	Officer	Mar 26 '25	Proposed Sale	70.87	22,500	1,594,534		Mar 26 04:14 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Option Exercise	45.28	9,500	430,129	56,436	Mar 13 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Sale	67.96	9,500	645,624	46,936	Mar 13 05:41 PM
Zovighian Bernard J	CEO	Mar 10 '25	Option Exercise	45.28	7,463	337,900	66,546	Mar 10 07:35 PM
Zovighian Bernard J	CEO	Mar 10 '25	Sale	69.51	6,164	428,448	59,083	Mar 10 07:35 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Option Exercise	45.28	400	18,111	22,988	Mar 10 07:34 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Sale	69.48	400	27,792	22,588	Mar 10 07:34 PM
Zovighian Bernard J	Officer	Mar 10 '25	Proposed Sale	69.51	6,164	428,448		Mar 10 04:13 PM
Lippis Daniel J.	Officer	Mar 10 '25	Proposed Sale	69.48	400	27,792		Mar 10 04:13 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Option Exercise	45.28	11,250	509,363	41,637	Feb 28 05:05 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Sale	70.78	11,250	796,327	30,387	Feb 28 05:05 PM
LORANGER STEVEN R	Director	Feb 14 '25	Option Exercise	45.32	5,739	260,073	66,111	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Sale	76.42	5,739	438,576	60,372	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Proposed Sale	76.42	5,739	438,576		Feb 14 04:11 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 13 '25	Option Exercise	45.28	11,250	509,363	41,811	Feb 13 06:04 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 13 '25	Sale	75.76	11,250	852,272	30,561	Feb 13 06:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '25	Option Exercise	45.28	6,500	294,299	53,436	Feb 13 06:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '25	Sale	75.75	6,500	492,363	46,936	Feb 13 06:04 PM
Lippis Daniel J.	CVP, JAPAC	Feb 13 '25	Option Exercise	45.28	500	22,638	23,689	Feb 13 06:04 PM
Lippis Daniel J.	CVP, JAPAC	Feb 13 '25	Sale	76.34	500	38,170	23,189	Feb 13 06:04 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Option Exercise	45.32	5,739	260,073	35,774	Feb 13 06:04 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Sale	75.86	5,739	435,371	30,035	Feb 13 06:04 PM
Lippis Daniel J.	Officer	Feb 13 '25	Proposed Sale	76.34	500	38,170		Feb 13 04:05 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Proposed Sale	75.86	5,739	435,371		Feb 13 04:04 PM
BOBO DONALD E JR	Officer	Feb 13 '25	Proposed Sale	75.75	25,500	1,931,579		Feb 13 04:03 PM
Lippis Daniel J.	CVP, JAPAC	Jan 16 '25	Option Exercise	45.28	500	22,638	23,689	Jan 16 05:07 PM
Lippis Daniel J.	CVP, JAPAC	Jan 16 '25	Sale	68.76	500	34,382	23,189	Jan 16 05:07 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 16 '25	Option Exercise	45.28	5,000	226,384	51,936	Jan 16 05:07 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 16 '25	Sale	68.75	5,000	343,736	46,936	Jan 16 05:07 PM
Lippis Daniel J.	Officer	Jan 16 '25	Proposed Sale	68.76	500	34,382		Jan 16 04:36 PM
Lippis Daniel J.	CVP, JAPAC	Dec 16 '24	Option Exercise	45.28	2,500	113,192	25,689	Dec 16 06:27 PM
Lippis Daniel J.	CVP, JAPAC	Dec 16 '24	Sale	74.08	2,500	185,196	23,189	Dec 16 06:27 PM
Lippis Daniel J.	Officer	Dec 16 '24	Proposed Sale	74.08	2,500	185,196		Dec 16 04:08 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '24	Option Exercise	45.28	11,250	509,363	41,811	Dec 09 04:58 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '24	Sale	71.68	11,250	806,406	30,561	Dec 09 04:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 09 '24	Option Exercise	45.28	5,000	226,384	51,936	Dec 09 04:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 09 '24	Sale	71.75	5,000	358,750	46,936	Dec 09 04:58 PM
Ullem Scott B.	Officer	Dec 09 '24	Proposed Sale	71.68	33,750	2,419,214		Dec 09 04:03 PM
Chopra Daveen	CVP, TMTT	Dec 06 '24	Sale	73.27	1,750	128,223	27,583	Dec 06 04:56 PM
Markowitz Wayne	GM & SVP, Surgical	Dec 06 '24	Sale	73.27	583	42,716	9,494	Dec 06 04:56 PM
Markowitz Wayne	Officer	Dec 06 '24	Proposed Sale	73.27	583	42,716		Dec 06 04:14 PM
Chopra Daveen	Officer	Dec 06 '24	Proposed Sale	73.27	1,750	128,222		Dec 06 04:12 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '24	Option Exercise	45.28	5,000	226,384	51,936	Nov 13 06:16 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '24	Sale	65.57	5,000	327,843	46,936	Nov 13 06:16 PM
BOBO DONALD E JR	Officer	Nov 13 '24	Proposed Sale	65.57	15,000	983,529		Nov 13 04:25 PM
Wood Larry L	Global President TAVR & Surg	Nov 05 '24	Sale	65.91	25,000	1,647,862	198,526	Nov 05 05:07 PM
Wood Larry L	Officer	Nov 05 '24	Proposed Sale	65.91	25,000	1,647,862		Nov 05 04:11 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 15 '24	Option Exercise	45.28	5,000	226,384	51,936	Oct 15 05:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 15 '24	Sale	69.51	5,000	347,534	46,936	Oct 15 05:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 11 '24	Option Exercise	45.28	5,000	226,384	51,936	Sep 11 06:06 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 11 '24	Sale	66.77	5,000	333,826	46,936	Sep 11 06:06 PM
Chopra Daveen	CVP, TMTT	Aug 20 '24	Sale	69.95	1,250	87,438	29,333	Aug 20 07:42 PM
Chopra Daveen	Officer	Aug 20 '24	Proposed Sale	69.95	1,250	87,438		Aug 20 05:12 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '24	Option Exercise	45.28	5,000	226,384	51,936	Aug 14 05:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '24	Sale	66.08	5,000	330,420	46,936	Aug 14 05:58 PM
BOBO DONALD E JR	Officer	Aug 14 '24	Proposed Sale	66.08	15,000	991,260		Aug 14 04:19 PM
Lippis Daniel J.	CVP, JAPAC	Jul 11 '24	Option Exercise	45.28	500	22,638	23,689	Jul 11 05:38 PM
Lippis Daniel J.	CVP, JAPAC	Jul 11 '24	Sale	94.18	500	47,090	23,189	Jul 11 05:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EW

Edwards Lifesciences Corp

Upgrade your FINVIZ experience